Caris Life Sciences, Inc. Common Stock (CAI) is a biotechnology company listed on NASDAQ.
Latest reported CAI revenue for 2025-12-31 was $812.0M. Net income was -$68.1M. Revenue was up 97.0% from 2024-12-31 to 2025-12-31. CAI currently screens at market cap $5.22B.
Use this CAI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CAI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CAI SEC filings page. Lician reads the product cache first so this HTML stays unique to Caris Life Sciences, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full CAI income, balance, and cash tables.